Skip to main content
David Penberthy, MD, Radiation Oncology, Charlottesville, VA

David Penberthy MD MBA (He/Him)


Associate Professor of Radiation Oncology

Join to View Full Profile
  • 1240 Lee StCharlottesville, VA 22908

  • Phone+1 434-924-9333

Dr. Penberthy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Virginia
    University of Virginia MBA, Business, 2009 - 2011
  • University of Virginia Medical Center
    University of Virginia Medical CenterResidency, Radiation Oncology, 1998 - 2002
  • National Capital Consortium
    National Capital ConsortiumInternship, Transitional Year, 1994 - 1995
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 1994

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2022 - 2027
  • NC State Medical License
    NC State Medical License 2022 - 2026
  • PA State Medical License
    PA State Medical License 2021 - 2026
  • VA State Medical License
    VA State Medical License 1995 - 2026
  • WV State Medical License
    WV State Medical License 2001 - 2015
  • GA State Medical License
    GA State Medical License 2006 - 2009
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Press Mentions

  • Transforming Cancer Care Delivery and Patient Experiences Through Technology with David Penberthy, MD, MBA
    Transforming Cancer Care Delivery and Patient Experiences Through Technology with David Penberthy, MD, MBAJune 28th, 2022
  • Ibrutinib Extends Survival for Older Mantle Cell Lymphoma Patients
    Ibrutinib Extends Survival for Older Mantle Cell Lymphoma PatientsJune 8th, 2022
  • Rucaparib Is Effective in Maintenance Treatment for Ovarian Cancer
    Rucaparib Is Effective in Maintenance Treatment for Ovarian CancerJune 8th, 2022
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: